I request help from experts about where in the FDA cGMP document / or other parts, the following have been mentioned.
1. Customer property as in ISO 13485, clause 7.5.4
2. Feedback as in ISO 13485, clause 8.2.1
3. Advisory notices as in ISO 13485, clause 8.5.1